By Jeffrey M. Haber The Anti-Retaliation Provisions of the False Claims Act The decision to blow the whistle is not an easy one to make, especially when the person blowing the whistle does so on his/her employer. A person’s career, financial security, reputation and sometimes personal safety can be at risk. This is true whether the person worked for the company that is the subject of a potential whistleblower (or “qui tam”) action. Recognizing the risks, Congress amended the

By Jeffrey M. Haber On December 22, 2016, the Department of Justice (“DOJ”) announced that Teva Pharmaceutical Industries Ltd. (“Teva”), the world’s largest manufacturer of generic pharmaceutical products, and its wholly-owned Russian subsidiary, Teva LLC (“Teva Russia”), agreed to resolve criminal charges and to pay a criminal penalty of more than $283 million for violating the Foreign Corrupt Practices Act (“FCPA”). The charges relate to various schemes involving the briber